BLOOD PRESSURE REDUCTION WITH THE NOVEL DUAL-ACTING ANGIOTENSIN RECEPTOR NEPRILYSIN INHIBITOR LCZ696: A RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED, ACTIVE-COMPARATOR STUDY
Michael Böhm, Luis M. Ruilope, Yves Lacourciere, Andrej Dukat, Jim Gong, Martin LefkowitzТом:
55
Рік:
2010
Мова:
english
DOI:
10.1016/s0735-1097(10)60585-2
Файл:
PDF, 64 KB
english, 2010